Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
9
Bearish filings
211
Named actors
17
Disclosed $ (bull / bear)
$281K + 2 of unknown size / $336.9M + 6 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-02 | Director Posner Brian S | bought | $40K | SEC ↗ |
| 2026-09-08 | CEO & President Cox John | sold | $107K | SEC ↗ |
| 2026-09-08 | Chief Medical Officer Kerr Douglas | sold | $24K | SEC ↗ |
| 2026-09-08 | Chief Commercial Officer Friedl-Naderer Johanna | sold | $3K | SEC ↗ |
| 2026-09-08 | Officer (via Stifel Nicolaus & Company Inc) Kerr Douglas | filed notice to sell | $661 | SEC ↗ |
195 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-08 | Officer (via Stifel Nicolaus & Company Inc) Cox John | filed notice to sell | $107K | SEC ↗ |
| 2026-09-04 | Chief Medical Officer Kerr Douglas | sold | $91K | SEC ↗ |
| 2026-09-04 | Chief Commercial Officer Friedl-Naderer Johanna | sold | $22K | SEC ↗ |
| 2026-09-04 | Officer (via Stifel Nicolaus & Company Inc) Kerr Douglas | filed notice to sell | $122K | SEC ↗ |
| 2026-08-14 | Director Rhodes Jason P | sold | $34.0M | SEC ↗ |
| 2026-08-14 | Director Rhodes Jason P | sold | $8.1M | SEC ↗ |
| 2026-08-14 | Director Rhodes Jason P | sold | $12.0M | SEC ↗ |
| 2026-08-14 | Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund II, LP | filed notice to sell | $12.4M | SEC ↗ |
| 2026-08-14 | Shareholder (via Merrill Lynch) Atlas Venture Fund XI, LP | filed notice to sell | $35.3M | SEC ↗ |
| 2026-08-14 | Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund I, LP | filed notice to sell | $8.4M | SEC ↗ |
| 2026-08-13 | CEO & President Cox John | sold | $131K | SEC ↗ |
| 2026-08-13 | Director Rhodes Jason P | sold | $1.7M | SEC ↗ |
| 2026-08-13 | Director Rhodes Jason P | sold | $2.5M | SEC ↗ |
| 2026-08-13 | Director Rhodes Jason P | sold | $7.0M | SEC ↗ |
| 2026-08-13 | Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund I, LP | filed notice to sell | $1.7M | SEC ↗ |
| 2026-08-13 | Shareholder (via Merrill Lynch) Atlas Venture Fund XI, LP | filed notice to sell | $7.0M | SEC ↗ |
| 2026-08-13 | Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund II, LP | filed notice to sell | $2.5M | SEC ↗ |
| 2026-08-13 | Chief Financial Officer Lucera Erick | sold | $47K | SEC ↗ |
| 2026-08-13 | Chief Medical Officer Kerr Douglas | sold | $41K | SEC ↗ |
| 2026-08-13 | Chief Commercial Officer Friedl-Naderer Johanna | sold | $6K | SEC ↗ |